KAS
ALDX icon

Kestra Advisory Services’s Aldeyra Therapeutics ALDX Stock Holding History

Kestra Advisory Services’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-17,138
Closed -$92K – 2253
2022
Q3 		$92K Sell
17,138
-800
-4% -$4.8K ﹤0.01% 1987
2022
Q2 		$72K Hold
17,938
– – ﹤0.01% 2013
2022
Q1 		$80K Buy
17,938
+1,129
+7% +$4.5K ﹤0.01% 1941
2021
Q4 		$67K Buy
16,809
+4,212
+33% +$32.1K ﹤0.01% 1963
2021
Q3 		$111K Hold
12,597
– – ﹤0.01% 2048
2021
Q2 		$143K Buy
12,597
+230
+2% +$2.77K ﹤0.01% 1923
2021
Q1 		$147K Sell
12,367
-7,400
-37% -$85.2K ﹤0.01% 1780
2020
Q4 		$135K Buy
+19,767
New +$139K ﹤0.01% 1763

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Kestra Advisory Services's ALDX Position: Q4 2022 in Review

Kestra Advisory Services sold out of Aldeyra Therapeutics (ALDX) in Q4 2022, closing a stake of 17,138 shares — an estimated $92K sold.

Kestra Advisory Services first reported a position in ALDX in Q4 2020 and held it in 8 quarters. The position peaked at $147K in Q1 2021. 96 funds tracked by Wall St. Rank hold ALDX as of Q4 2022.

  • Kestra Advisory Services reported no remaining Aldeyra Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Kestra Advisory Services sold 17,138 Aldeyra Therapeutics shares in Q4 2022, an estimated $92K.
  • Kestra Advisory Services first reported a position in Aldeyra Therapeutics in Q4 2020 and held it in 8 quarters.
  • Kestra Advisory Services's Aldeyra Therapeutics position peaked at $147K in Q1 2021.
  • 96 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q4 2022.

Based on Kestra Advisory Services's 13F filing for Q4 2022, filed 31 Jan 2023.